Retension Pharmaceuticals, Inc. Common Stock (RTSN) is a publicly traded the market company. As of October 13, 2026, RTSN trades at $11.81 with a market cap of $89.22M and a P/E ratio of 0.00. RTSN moved +4.95% today. Year to date, RTSN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $9.66 to $11.79. Rallies surfaces RTSN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Retension Pharmaceuticals, Inc. Common Stock (RTSN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RTSN moved +4.95% today.
| Metric | Value |
|---|---|
| Price | $11.81 |
| Market Cap | $89.22M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.79 |
| 52-Week Low | $9.66 |
| Volume | 122.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
RTSN analyst coverage data. Average price target: $0.00.